Add to Calendar   Friday, April 5, 2024 12:45 PM Friday, April 5, 2024 1:45 PM ET VONVENDI Prophylaxis for Severe Type 3 von Willebrand Disease - Patient Case Discussion (Sponsored by Takeda Pharmaceuticals) THSNA aYaMRExkLzQZmPlsLmNx65599
VONVENDI Prophylaxis for Severe Type 3 von Willebrand Disease - Patient Case Discussion (Sponsored by Takeda Pharmaceuticals)
  Friday, April 5, 2024           12:45 PM - 1:45 PM ET
 


Description

Join our expert HCP and a patient living with von Willebrand Disease (VWD) for an interactive journey. Our panel will guide you through the patient�s experience with VWD, review their treatment history, and discuss how VONVENDI may be added to the treatment plan for prophylaxis.


This Content is Locked.
Log into a registered attendee account that includes registration for this event/session to access this content.